NAKAGAWA; Hidewaki

Patent Applications and Registrations

Patent applications and USPTO patent grants for NAKAGAWA; Hidewaki.The latest application filed is for "analysis method for assessing stage of prostate cancer, prostate-cancer stage assessment method, prostate-cancer detection method, and test kit".

Company Profile

0.7.17

NAKAGAWA; Hidewaki - Saitama US
NAKAGAWA; HIDEWAKI - TOKYO JP
Nakagawa; Hidewaki - Kanagawa N/A JP
Nakagawa; Hidewaki - Bunkyo-ku JP
Nakagawa; Hidewaki - Shinagawa-ku JP

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Analysis Method For Assessing Stage Of Prostate Cancer, Prostate-cancer Stage Assessment Method, Prostate-cancer Detection Method, And Test Kit App 20160003831 - UEDA; Koji ; et al.	2016-01-07
Methods For Diagnosing Or Treating Prostate Cancer App 20130302799 - NAKAMURA; YUSUKE ; et al.	2013-11-14
Lung cancer diagnostic polypeptide, method for detecting lung cancer, and method for evaluating therapeutic effect Grant 8,518,654 - Ueda , et al. August 27, 2	2013-08-27
Methods for diagnosing or treating prostate cancer Grant 8,420,329 - Nakamura , et al. April 16, 2	2013-04-16
Prostate cancer related gene STYK1 Grant 8,182,997 - Nakamura , et al. May 22, 2	2012-05-22
Lung Cancer Diagnostic Polypeptide, Method For Detecting Lung Cancer, And Method For Evaluating Therapeutic Effect App 20120040376 - Ueda; Koji ; et al.	2012-02-16
PKIB and NAALADL2 for Target Genes of Prostate Cancer Therapy and Diagnosis App 20120022128 - Nakamura; Yusuke ; et al.	2012-01-26
Methods For Diagnosing Or Treating Prostate Cancer App 20110294123 - Nakamura; Yusuke ; et al.	2011-12-01
Genes and polypeptides relating to prostate cancers Grant 8,067,153 - Nakamura , et al. November 29, 2	2011-11-29
C12orf48 As A Target Gene For Cancer Therapy And Diagnosis App 20110263679 - Nakamura; Yusuke ; et al.	2011-10-27
Pancreatic Cancer Related Gene Ttll4 App 20110251090 - Nakamura; Yusuke ; et al.	2011-10-13
Prostate Cancer Related Gene Styk1 App 20110135654 - Nakamura; Yusuke ; et al.	2011-06-09
C2orf18 As Target Gene For Cancer Therapy And Diagnosis App 20110098339 - Nakamura; Yusuke ; et al.	2011-04-28
Genes And Polypeptides Relating To Prostate Cancers App 20090220512 - Nakamura; Yusuke ; et al.	2009-09-03
Method for diagnosing pancreatic cancer App 20090162361 - Nakamura; Yusuke ; et al.	2009-06-25
Methods For Diagnosing Pancreatic Cancer Using Reg4 Protein App 20090155799 - Nakamura; Yusuke ; et al.	2009-06-18
Genes and polypeptides relating to prostate cancers Grant 7,521,205 - Nakamura , et al. April 21, 2	2009-04-21
Pin-Prc Transition Genes App 20080063640 - Nakamura; Yusuke ; et al.	2008-03-13
Epha4 As Therapeutic Target Of Prc And Pdaca App 20070253954 - Nakamura; Yusuke ; et al.	2007-11-01
Genes and polypeptides relating to prostate cancers App 20060160991 - Nakamura; Yusuke ; et al.	2006-07-20
Genes and polypeptides relating to prostate cancers App 20050259483 - Nakamura, Yusuke ; et al.	2005-11-24
Method for diagnosing pancreatic cancer App 20050260639 - Nakamura, Yusuke ; et al.	2005-11-24

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.